What is China Dasheng Biotechnology Company (CDBT)?

China Dasheng Biotechnology Company (CDBT) is a stock in the Financial Services sector, Shell Companies industry. View full analysis on Stocks360.

What is the current price of CDBT?

The current price of CDBT is $0.10. Prices are updated in real time on Stocks360.

What is CDBT's price-to-earnings (PE) ratio?

CDBT's trailing twelve-month PE ratio is -4.24, based on current price and earnings per share data available on Stocks360.

What is CDBT's market capitalization?

CDBT's market capitalization is $4,097,600.00, placing it in the small-cap tier.

China Dasheng Biotechnology Company (CDBT)

Stock analysis · OTC · Financial Services · Shell Companies

$0.10

Market Cap

$4.10M

PE (TTM)

-4.24

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

2.26

Day Range

$0.06 – $0.10

52-wk Range

$0.00 – $0.15

Avg Volume

N/A

Volume

10.00K

China Dasheng Biotechnology Company (CDBT) is a publicly traded company in the Financial Services sector. Latest price: $0.10. Market cap $4.10M. Trailing PE -4.24. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About China Dasheng Biotechnology Company

China Dasheng Biotechnology Company, alongside its various divisions, is dedicated to the creation, promotion, and distribution of microbial products within the People's Republic of China. These specialized solutions primarily function as beneficial additives for both livestock feed and agricultural cultivation. The company's product line features proprietary blends of Artificial Microorganisms (AM) and High-efficiency Microorganisms (HM), in addition to biological preservatives. Its AM/HM bacteria-based additives for crops, including specific strains like Bulgaria lactobacillus, beer microzyme, and dark red spirilla, are formulated to significantly boost beneficial microbial populations in soil. They also work to counteract the proliferation of harmful fungi and putrefactive bacteria, thereby optimizing nutrient absorption and helping to reduce the incidence of diseases in both plants and animals. For animal nutrition, the AM/HM bacteria-based feed additives are designed to improve the texture of livestock feed and inhibit the growth of pathogenic bacteria. Moreover, they deliver essential nutrients such as organic acids, vitamins, enzymes, natural antibiotics, mycelial protein,…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-4.24×
P/S (TTM)	0.00×
P/B	-3.38×
PEG	0.06×
P/FCF (TTM)	-17.54×
EV / EBITDA	-8.04×
EV / Sales	0.00×
Earnings Yield	-23.60%
Free Cash Flow Yield	-5.70%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$5.12M
Net Income (TTM)	-$967.00K
Free Cash Flow (TTM)	$126.28K
Net Debt	$1.02M
Working Capital	-$1.57M
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Return on Equity	155.49%
Return on Invested Capital	354.68%